For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of this treatment and the formulated version represents a true breakthrough . These innovative therapies stabilize the transthyretin protein, slowing its destructive build-up and lessening the burden of the illness. Individuals are now exp